Company Analysis

ProKidney Corp. (PROK)

Nasdaq: PROK · Biological Products, (No Diagnostic Substances) · Winston-Salem, NC · filing with the SEC since 2021
Grade5.3
◀ Past 5.6● Present 3.6▶ Future 6.5
3 est.

Who runs ProKidney Corp.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Culleton Bruce
Chief Executive Officer. First filing Jul 2023, latest Nov 3, 2026, 0 filings in all.
Officers reporting now
5
of 12 people with a filing in the last fifteen months
Directors reporting now
7
25 people on the record since 2021
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Culleton BruceChief Executive OfficerJul 2023Nov 3, 2026none
Weber Darin J.Chief Regulatory OfficerJul 2022Oct 30, 2026none
Locke Kenneth ThomasChief Technical OfficerJun 2026Jul 6, 2026none
Girolamo Todd CChief Legal OfficerJul 2022Jun 15, 2026none
Coulston JamesChief Financial OfficerJul 2022Mar 3, 2026none
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Pereira Brian JgdirectorJul 2022Aug 20, 202610 · $3.0M
Doyle William FdirectorJul 2022May 29, 2026none
Fox Jennifer A.directorJul 2022May 29, 2026none
Jimenez Santos Jose IgnaciodirectorJul 2022May 29, 2026none
Legorreta Pablo G.directorJul 2022May 29, 2026none
Lotvin AlandirectorJul 2022May 29, 2026none
Sinha UmadirectorSep 2021May 29, 2026none
Owners of more than 10% of a classsales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Control Empresarial De Capitales S.A. De C.V.10% ownerJul 2022Apr 30, 2026none
Earlier names on the record17, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PROK · research, not advice